INDPIndaptus Therapeutics Inc. Common Stock
1.290USD+37.23%Mkt Cap: 171.88M $P/E: —3d ago
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to pr…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap171.88M $
Enterprise Value172.32M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-20.85M $
Revenue/Share—
Last Price1.290 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.99
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B125.45
EPS (TTM)-5.17
EPS (Forward)-1.39
52W Range
0.92005% of range8.570
52W High8.570 USD
52W Low0.9200 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-661.54%
ROA-223.94%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.82M $
CapEx (TTM)—
FCF Margin—
FCF Yield-5.48%
Net Debt-11.55M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.00
Current Ratio19.48
Quick Ratio18.77
Book Value/Sh0.0110 USD
Cash/Share0.0870 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 30, 2020
Splits
Last Split1:28
Split DateJun 27, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.133.24M
Float3.82M
Insiders82.45%
Institutions0.30%
Short Interest
Short Ratio1.0d
Short % Float0.07%
Short % Out.0.07%
Shares Short93.14K
Short (prev mo.)137.59K
Technical
SMA 502.379 (-45.8%)
SMA 2002.272 (-43.2%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)166.21K
Avg Vol (10d)1.40M
Technical Indicators
RSI (14)40.4
MACD-0.3741
MACD Signal-0.3953
MACD Hist.+0.0212
BB Upper2.464 USD
BB Middle1.444 USD
BB Lower0.4251 USD
BB Width141.15%
ATR (14)0.2692 USD
Vol Ratio (20d)6.44x